StockData

Novavax Inc (NVAX) stock

NVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$7.96+0.00 (0.00%)

Close on Nov 18, 2026Market cap $1.31BP/E –Yield –

Novavax total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

For fiscal 2015 it was $395.00K, down 60.4% from the year before. The highest annual figure on record is $1.88M in fiscal 2013.

Annual total debt

PeriodPeriod endValueChange
FY2015Dec 31, 2015$395.00K-60.4%
FY2014Dec 31, 2014$998.00K-46.9%
FY2013Dec 31, 2013$1.88M+149.8%
FY2012Dec 31, 2012$753.00K+151.0%
FY2011Dec 31, 2011$300.00K-6.3%
FY2010Dec 31, 2010$320.00K–

More Novavax figures

See a number that looks wrong?